An official website of the United States government
Here's how you know
A .mil website belongs to an official U.S. Department of Defense organization in the United States.
A lock (lock ) or https:// means you’ve safely connected to the .mil website. Share sensitive information only on official, secure websites.


NEWS | Feb. 1, 2021

DOD Awards $231.8 Million Contract to Ellume USA LLC to Increase Domestic Production Capacity and Deliver COVID-19 Home Tests

By Press Release

FOR IMMEDIATE RELEASE - On Feb. 1, 2021, the Department of Defense (DOD), in coordination with the Department of Health and Human Services, awarded $231.8 million to Ellume USA LLC to onshore production capacity of the Ellume COVID-19 Home Test for the United States.

This industrial base expansion effort will allow Ellume USA LLC to increase production capacity of the Ellume COVID-19 Home Test in the United States by 640,000 tests per day by December 2021, to support domestic COVID-19 testing.  The expansion includes the procurement of 8.5 million tests that will be distributed across the U.S. in accordance with the National Strategy for the COVID-19 Response and Pandemic Preparedness policy established January 21, 2021. 

Ellume’s COVID-19 Home Test is the first fully at-home diagnostic test to receive a Food and Drug Administration (FDA) Emergency Use Authorization (EUA) for the detection of COVID-19 in individuals with or without symptoms.  The test will be able to be purchased without a prescription and utilized in an at-home setting, without assistance from a physician or health care provider.  The test can be performed in approximately 15 minutes from a nasal swab specimen with results reported via a smartphone app.

Development of Ellume’s COVID-19 Home Test was supported by the National Institutes of Health (NIH)’s Rapid Acceleration of Diagnostics (RADx) initiative program beginning in May 2020.

The DOD’s Joint Program Executive Office for Chemical, Biological, Radiological, and Nuclear Defense (JPEO-CBRND) led this effort, in coordination with the DOD’s Defense Assisted Acquisition (DA2) Cell. This effort was funded through the Health Care Enhancement Act (HCEA), to support domestic production of critical medical resources.


Download our press kit, which includes helpful documents to better understand our work, such as – Command Brief, Chemical Biological Defense Program's Enterprise strategy, the JPEO-CBRND's Capabilities Catalog, Leadership Biographies, COVID-19 fact sheets, and contracting overview documents.  



JPEO-CBRND Public Affairs Office

The JPEO-CBRND Public Affairs Office coordinates and responds to all public affairs and media relations needs on behalf of the JPEO-CBRND. To request a speaker, subject matter expert, or for other interview or request for comment please email our Public Affairs Office email below.